Compounds > 1,3,4-oxadiazole
Page last updated: 2024-08-26

1,3,4-oxadiazole and Carcinoma, Ductal, Pancreatic

1,3,4-oxadiazole has been researched along with Carcinoma, Ductal, Pancreatic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Carbone, D; Cascioferro, S; Diana, P; Giovannetti, E; Panzeca, G; Parrino, B; Pecoraro, C; Roeten, MSF; Xu, G1

Other Studies

1 other study(ies) available for 1,3,4-oxadiazole and Carcinoma, Ductal, Pancreatic

ArticleYear
1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivatives against Pancreatic Ductal Adenocarcinoma: Synthesis, Cytotoxic Activity, and Inhibition of CDK1.
    Marine drugs, 2023, Jul-19, Volume: 21, Issue:7

    Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Pancreatic Ductal; CDC2 Protein Kinase; Cell Line, Tumor; Cell Proliferation; Humans; Pancreatic Neoplasms

2023